Compared to controls, COVID-19 patients had relatively higher SP-A levels in their saliva, an increase that is suggestive of SP-A’s innate immune roles during an acute infection prior to the induction of the adaptive immune response. This evidence concerns the gene SFTPA2 and COVID-19.